Cargando…
Decoy Plasminogen Receptor Containing a Selective Kunitz-Inhibitory Domain
[Image: see text] Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in which P2′ residue Leu17 (bovine pancreatic trypsin inhibitor numbering) is mutated to Arg selectively inhibits the active site of plasmin with ∼5-fold improved affinity. Thrombin cleavage (24 h extended incubation at a 1...
Autores principales: | Kumar, Yogesh, Vadivel, Kanagasabai, Schmidt, Amy E., Ogueli, Godwin I., Ponnuraj, Sathya M., Rannulu, Nalaka, Loo, Joseph A., Bajaj, Madhu S., Bajaj, S. Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985851/ https://www.ncbi.nlm.nih.gov/pubmed/24383758 http://dx.doi.org/10.1021/bi401584b |
Ejemplares similares
-
Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1
por: Vadivel, Kanagasabai, et al.
Publicado: (2020) -
An Estimate of the Numbers and Density of Low-Energy Structures (or Decoys) in the Conformational Landscape of Proteins
por: Vadivel, Kanagasabai, et al.
Publicado: (2009) -
Identification of protein targets in cerebral endothelial cells for brain arteriovenous malformation (AVMs) molecular therapies
por: Simonian, Margaret, et al.
Publicado: (2017) -
The heterodimeric structure of heterogeneous nuclear ribonucleoprotein C1/C2 dictates 1,25-dihydroxyvitamin D-directed transcriptional events in osteoblasts
por: Lisse, Thomas S, et al.
Publicado: (2014) -
S. mansoni SmKI-1 Kunitz-domain: Leucine point mutation at P1 site generates enhanced neutrophil elastase inhibitory activity
por: Mambelli, Fábio, et al.
Publicado: (2021)